The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Full article: Compounded glucagon like peptide 1 receptor agonists for weight loss: the direct to consumer market in Colorado The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157 Banned: Key Facts on the Latest FDA Decision Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services